av/telo-genomics--big.svg

TSX:TELO

Telo Genomics Corp.

  • Stock

Last Close

0.20

30/08 17:22

Volume Today

500

Avg: 17.66K

PE Ratio

−3.97

PFCF: −4.28

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
net income
-37.19K
-
-108.73K
192.36%
-70.05K
35.57%
-9.91M
14,051.29%
-4.69M
52.64%
-1.07M
77.12%
-1.24M
15.59%
-1.07M
13.83%
-2.11M
97.25%
-2.82M
33.66%
depreciation and amortization
110.36K
-
124.33K
12.66%
82.91K
33.31%
64.72K
21.94%
62.23K
3.85%
56.96K
8.47%
33.11K
41.86%
deferred income tax
610.26K
-
102.26K
83.24%
-3.75K
-
-206.57K
5,408.45%
-252.18K
22.08%
stock based compensation
1.31M
-
58.69K
95.52%
43.35K
26.14%
359.50K
729.28%
141.55K
60.63%
151.41K
6.96%
160.17K
5.79%
change in working capital
1.72K
-
1.96K
14.08%
-8.60K
538.45%
-1.35M
15,583.72%
1.22M
190.79%
320.10K
73.85%
-206.39K
164.48%
-51.12K
75.23%
107.10K
309.53%
-2.07K
101.93%
accounts receivables
-279.56K
-
292.02K
204.46%
3.93K
98.65%
-12.66K
422.10%
-47.47K
274.77%
58.75K
223.78%
-25.79K
143.89%
inventory
accounts payables
other working capital
-1.07M
-
932.24K
187.21%
316.16K
66.09%
-193.72K
161.27%
-3.65K
98.12%
48.35K
1,424.55%
23.72K
50.94%
other non cash items
1.94M
-
-21.36K
101.10%
300K
1,504.82%
-95.70K
131.90%
-183.48K
91.73%
206.57K
212.58%
252.18K
22.08%
net cash provided by operating activities
-35.47K
-
-106.77K
201.00%
-78.65K
26.34%
-7.90M
9,944.20%
-3.21M
59.41%
-327.84K
89.78%
-1.12M
241.50%
-1.10M
1.34%
-1.79M
62.51%
-2.63M
46.49%
investments in property plant and equipment
-477.72K
-
-23.17K
95.15%
-8.67K
-
-9.31K
7.37%
-25.19K
170.60%
-69.06K
174.13%
acquisitions net
139.95K
-
purchases of investments
sales maturities of investments
other investing activites
-250K
-
-25.19K
89.92%
1.15K
104.56%
net cash used for investing activites
-250K
-
-139.26K
44.30%
-22.02K
84.19%
-8.67K
-
-9.31K
7.37%
-25.19K
170.60%
-69.06K
174.13%
debt repayment
-101.11K
-
-280K
-
-350K
25%
-15K
95.71%
-7.50K
-
common stock issued
9.95M
-
2.12M
78.67%
1.74M
-
2.09M
20.58%
195K
90.68%
2.83M
1,353.27%
common stock repurchased
dividends paid
other financing activites
-648.25K
-
-27.28K
95.79%
560K
2,153.01%
644.22K
15.04%
1.75M
171.90%
681.65K
61.08%
-147.47K
121.63%
net cash used provided by financing activities
60K
-
187.26K
212.11%
9.20M
4,813.31%
2.10M
77.23%
280K
86.64%
2.03M
624.90%
3.83M
88.66%
876.65K
77.11%
2.68M
205.59%
effect of forex changes on cash
net change in cash
-35.47K
-
-46.77K
31.85%
-141.39K
202.31%
1.16M
921.67%
-1.13M
197.53%
-47.84K
95.78%
901.49K
1,984.54%
2.72M
201.23%
-943.54K
134.75%
-19.72K
97.91%
cash at beginning of period
542.17K
-
506.70K
6.54%
459.93K
9.23%
38.66K
91.59%
1.20M
3,004.76%
67.33K
94.39%
19.50K
71.05%
920.98K
4,624.20%
3.64M
294.85%
2.69M
25.95%
cash at end of period
506.70K
-
459.93K
9.23%
318.54K
30.74%
1.20M
276.84%
67.33K
94.39%
19.50K
71.05%
920.98K
4,624.20%
3.64M
294.85%
2.69M
25.95%
2.67M
0.73%
operating cash flow
-35.47K
-
-106.77K
201.00%
-78.65K
26.34%
-7.90M
9,944.20%
-3.21M
59.41%
-327.84K
89.78%
-1.12M
241.50%
-1.10M
1.34%
-1.79M
62.51%
-2.63M
46.49%
capital expenditure
-477.72K
-
-23.17K
95.15%
-8.67K
-
-9.31K
7.37%
-25.19K
170.60%
-69.06K
174.13%
free cash flow
-35.47K
-
-106.77K
201.00%
-78.65K
26.34%
-8.38M
10,551.59%
-3.23M
61.45%
-327.84K
89.85%
-1.13M
244.15%
-1.11M
1.28%
-1.82M
63.41%
-2.70M
48.26%

All numbers in (except ratios and percentages)